Cho BC, Ahn MJ, Kang JH, Soo RA, et al. Lazertinib Versus Gefitinib as First-line Treatment in Patients With EGFR-mutated Advanced Non-Small Cell Lung Cancer (NSCLC): Results From LASER301. J Clin Oncol 2023 Jun 28:101200JCO2300515. doi: 10.1200/JCO.23.00515.
PMID: 37379502